鞘内吗啡不能预防择期剖宫产术后慢性疼痛:一项随机对照试验
这项随机双盲安慰剂对照试验纳入290名健康择期剖宫产产妇,比较鞘内吗啡100μg与生理盐水对慢性术后疼痛(CPSP)的影响。3个月随访时吗啡组CPSP发生率为19%(27/139),安慰剂组为18%(25/137),差异无统计学意义(OR 1.08,95%CI 0.59-1.97,P=0.803);6个月时两组也无显著差异。结论认为鞘内吗啡100μg不能降低择期剖宫产术后3个月和6个月的慢性疼痛发生率。
要点
- 鞘内吗啡100μg不降低剖宫产术后3个月CPSP发生率(19% vs 18%)。
- 6个月CPSP发生率两组相似(16% vs 14%),无统计学差异。
- 疼痛严重程度和干扰评分在3个月和6个月时两组间无差异。
核心结论
- 择期剖宫产脊麻中给予吗啡100μg未能降低术后3个月和6个月的慢性疼痛发生率。
研究设计与样本
- 随机、双盲、安慰剂对照试验,纳入290名健康择期剖宫产产妇,按1:1随机接受鞘内吗啡100μg(n=145)或生理盐水(n=145),麻醉和术后镇痛标准化。
主要发现
- 3个月随访时吗啡组CPSP发生率为19%(27/139),安慰剂组为18%(25/137),OR 1.08(95%CI 0.59-1.97),P=0.803。
- 6个月时吗啡组CPSP发生率为16%(23/139),安慰剂组为14%(19/137),OR 1.23(95%CI 0.63-2.38),P=0.536。
- 简明疼痛量表(BPI)评估的疼痛严重程度和疼痛干扰评分在3个月和6个月时两组相似。
临床怎么用
- 择期剖宫产脊麻中添加吗啡100μg不应以预防慢性术后疼痛为目的。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Morphine is frequently added to spinal anaesthesia for Caesarean delivery. We aimed to determine whether intrathecal morphine for spinal anaesthesia decreases the risk of chronic postsurgical pain (CPSP). METHODS: In this randomised, double-blind, placebo-controlled trial, 290 healthy parturients undergoing elective Caesarean delivery were randomly assigned in a 1:1 ratio to receive either intrathecal morphine 100 μg (n=145) or normal saline (control; n=145) as a part of spinal anaesthesia. Anaesthetic care and postoperative pain management were standardised in all patients. The primary outcome was the incidence of CPSP at 3 months. Secondary outcomes included CPSP at 6 months, pain severity, and pain interference, measured by the Brief Pain Inventory questionnaire using an 11-point numeric rating scale, at 3 and 6 months after the surgery. RESULTS: Two hundred and seventy-six patients completed the 3-month follow-up, 139 in the morphine group and 137 in the placebo group. The incidences of CPSP at 3 months were 19% (27 of 139) in the morphine group and 18% (25 of 137) in the placebo group (odds ratio, 1.08; 95% confidence interval, 0.59-1.97; P=0.803). At 6 months, CPSP was present in 23 of 139 (16%) morphine group patients compared with 19 of 137 (14%) in the placebo group (odds ratio, 1.23; 95% confidence interval, 0.63-2.38; P=0.536). Brief Pain Inventory questionnaire scores for pain severity and pain interference at 3 and 6 months were similar between groups. CONCLUSIONS: Administration of morphine 100 μg as a component of spinal anaesthesia for elective Caesarean delivery failed to reduce the incidence of chronic pain at 3 and 6 months after surgery. CLINICAL TRIAL REGISTRATION: NCT03451695.
引用
- Subedi A, Schyns-van den Berg AMJV, Thapa P, et al. Intrathecal morphine does not prevent chronic postsurgical pain after elective Caesarean delivery: a randomised controlled trial. Br J Anaesth. 2022. PMID: 35090722. doi:10.1016/j.bja.2021.11.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。